39416 Federal Register / Vol. 65, No. 123 / Monday, June 26, 2000 / Notices

II. 2001 CFSAN Program Priorities

FDA is requesting comments

concerning the establishment of

program priorities in CFSAN for FY

2001. The input will be used to develop

CFSAN’s 2001 workplan. The workplan

will set forth the Center’s program

priorities for October 1, 2000, through

September 30, 2001. FDA intends to

make the 2001 workplan available in

October 2000.

The format of the 2001 workplan will

be similar to the 2000 workplan.

Moreover, FDA expects there will be

considerable continuity between the

2000 and 2001 workplans. For example,

a broad program area targeted for

enhancement in the 2000 plan is

improving the safety of imported food;

five specific activities are identified to

implement the Imported Foods Action

Plan. As the initiative to prevent

importation of unsafe food requires a

multiyear effort, ensuring the safety of

imported food will continue to be a high

priority in the 2001 workplan. The same

is true for the Egg Safety Action Plan.

FDA requests comments on other broad

program areas that should continue to

be a priority in FY 2001.

In addition, because the 2000

workplan, as noted above, was a

condensed (i.e., 9-month) plan, our goal

for FY 2000 will be to fully complete at

least three-quarters of the ‘‘A’’ list

activities. FDA requests comments on

those ‘‘A’’ list activities in the 2000 plan

that, if not completed, should be carried

over to the 2001 workplan. FDA also

requests comments on the FY 2000 ‘‘B’’

list activities that should be elevated to

the ‘‘A’’ list for completion in FY 2001.

Finally, FDA requests comments on new

program areas or activities that should

be a high priority for FY 2001.

Interested persons may submit to the

Dockets Management Branch (address

above) written comments regarding this

notice by August 25, 2000. Two copies

of any comments are to be submitted,

except that individuals may submit one

copy. Comments are to be identified

with the docket number found in

brackets in the heading of this

document. Received comments may be

seen in the office between 9 a.m. and 4

p.m., Monday through Friday.

Dated: June 19, 2000.

Margaret M. Dotzel,

Associate Commissioner for Policy.

[FR Doc. 00–16067 Filed 6–23–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Medical Imaging Drugs Advisory

Committee; Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). The meeting will be open to the

public.

Name of Committee: Medical Imaging

Drugs Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.

Date and Time: The meeting will be

held on July 10, 2000, 8:30 a.m. to 5:30

p.m.

Location: Holiday Inn, Versailles

Ballrooms I and II, 8120 Wisconsin

Ave., Bethesda, MD.

Contact Person: Thomas H. Perez,

Center for Drug Evaluation and Research

(HFD–21), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–6758, email at PerezT@cder.fda.gov, or FDA

Advisory Committee Information Line,

1–800–741–8138 (301–443–0572 in the

Washington, DC area), code 12540.

Please call the Information Line for upto-date information on this meeting.

Agenda: The committee will discuss

biologic license application (BLA) 99–

1407, LeutechTM (Technicium labeled

TC99M anti/CD15 antibody injection),

Palatin Technologies, Inc., imaging

agent as an aid in the diagnosis of

equivocal appendicitis.

Procedure: Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by July 3, 2000. Oral

presentations from the public will be

scheduled between approximately 1

p.m. and 2 p.m. Time allotted for each

presentation may be limited. Those

desiring to make formal oral

presentations should notify the contact

person before July 3, 2000, and submit

a brief statement of the general nature of

the evidence or arguments they wish to

present, the names and addresses of

proposed participants, and an

indication of the approximate time

requested to make their presentation.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: June 19, 2000.

Linda A. Suydam,

Senior Associate Commissioner.

[FR Doc. 00–16065 Filed 6–23–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–R–0282]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Request:

Reinstatement, without change, of a

previously approved collection; Title of

Information Collection:

Medicare+Choice (M+C) Organization

Appeals and Grievance Data Disclosure

Requirements and Supporting

Regulations in 42 CFR 422.64, 422.111,

and 422.560–422.622; HCFA Form

Number: HCFA–R–0282 (OMB approval

#: 0938–0778); Use: These information

collection pertains to the aggregate

number and disposition of grievances

and appeals by M+C organizations. Both

the Balanced Budget Act (BBA) of 1997

and the Government Performance and

Results Act (GPRA) of 1993 establish a

need for HCFA to set and monitor

performance standards in the area of

appeals. The purpose is to hold M+C

organizations accountable to regulators

and consumers, as well as promote

informed choice; Frequency: Semiannually; Affected Public: Business or

other for-profit; Number of

Respondents: 268; Total Annual